| BEVASIRANIB | Oligonucleotide | none | Toll-like receptor 3 activator | 3 | ['Completed', 'Completed', 'Withdrawn', 'Completed', 'Terminated'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |
| RINTATOLIMOD | Oligonucleotide | none | Toll-like receptor 3 agonist | 3 | ['Recruiting', 'Completed', 'Active, not recruiting', 'Completed', 'Terminated', 'Recruiting', 'Active, not recruiting', 'Terminated', 'Recruiting', 'Terminated', 'Recruiting', 'Completed', 'Not yet recruiting', 'Suspended', 'Recruiting', 'Completed'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |